Anaerobic Digestion Open Access Journals
Anaerobic digestion (AD) involves a consortium of microorganisms that convert substrates into
biogas containing methane for renewable energy. The technology has suffered from the
perception of being periodically unstable due to limited understanding of the relationship between
microbial community structure and function. The emphasis of this review is to describe
microbial communities in digesters and quantitative and qualitative relationships between community structure and digester function. Progress has been made in the past few decades to identify key microorganisms influencing AD. Yet, more work is required to realize robust, quantitative relationships between
microbial community structure and functions such as methane production rate and resilience after perturbations. Other promising areas of research for improved AD may include methods to increase/control hydrolysis rate, direct interspecies electron transfer to methanogens, community structure–function relationships of methanogens, methanogenesis via acetate oxidation, and bioaugmentation to study community–activity relationships or improve engineered bioprocesses. Anaerobic Digestion Open Access Journals Anaerobic digestion (AD) is a series of natural biological processes whereby organic
waste material is broken down by micro-organisms and converted into energy, known as biogas.A typical anaerobic digester is a sealed vessel, or series of vessels, in which bacteria act without
High Impact List of Articles
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
Statistical issues in trial design and personalized medicine
Feifang Hu
Editorial: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical